"Small molecule drugs are chemically derived and simpler to make and can usually be taken orally by patients. These drugs -- think medicine cabinet essentials like aspirin or statins -- dominated the pharmaceutical industry during the 20th century.
"Biologics -- therapies that are extracted from living organisms -- are usually given through an injection and, because of their higher price tags, make up the bulk of today's top-selling drugs. While biologics are at the cutting edge of medicine, discoveries of new small-molecule drugs continue to be made." [1]
1. EXCHANGE --- Heard on the Street: The Prognosis for Drug Cures --- New legislation won't kill innovation. It will change how pharma capital is allocated.
Wainer, David. Wall Street Journal, Eastern edition; New York, N.Y. [New York, N.Y]. 07 Jan 2023: B.14.
Komentarų nėra:
Rašyti komentarą